In vivo experiments performed in a diethylnitrosamine (DEN) HCC mouse model with hepatocyte-specific knockout of the IL-6 receptor gp130 have demonstrated a reduced number of liver tumor nodules and macrophages compared to their control counterparts, supporting a role for IL-6 in HCC formation [24]. Here, IL6 is linked to hepatocellular carcinoma.